Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2010
12/22/2010CN1902186B Thiazole and pyrazole derivatives as FLT-3 kinase inhibitors
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1802366B C-glycoside derivatives and salts thereof
12/22/2010CN101925596A Beta-amino acid derivatives for treatment of diabetes
12/22/2010CN101925588A 2-cyanophenyl sulfonamide derivatives useful as pesticides
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921232A Salt of 2-ring substituted pyrazolone azo derivatives, and preparation method and application thereof in medicaments
12/22/2010CN101381364B Starburst molecule containing 2,4,6-tri(2-thineyl)-1,3,5-s-triazine unit and preparation method thereof and use
12/21/2010US7855297 Amide derivatives and medicinal use thereof
12/21/2010US7855226 Treatment of inflammatory bowel disease
12/21/2010US7855219 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
12/21/2010US7855215 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia
12/21/2010US7855212 Pyridinyl acetonitriles
12/21/2010US7855207 such as 6-[(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-piperidin-1-ylpropyl]-3-ethyl-1H-quinolin-2-one, used for treating cancer and/or preventing cellular, tissue and/or organ damage resulting from cell damage or death due to, for example, necrosis or apoptosis
12/21/2010US7855203 Indazolyl-substituted pyrroline compounds as kinase inhibitors
12/21/2010US7855198 Benzamide derivative or salt thereof
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010CA2492718C Prodrugs of proton pump inhibitors
12/21/2010CA2457575C 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same
12/21/2010CA2452596C Benzo-fused 5-membered heterocyclic compounds, their production and use
12/21/2010CA2423351C Novel arylalkane-sulfonamides
12/21/2010CA2404594C Agent for prophylaxis and treatment of renal disease
12/21/2010CA2401778C Benzamides and related inhibitors of factor xa
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/16/2010WO2010144664A1 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
12/16/2010WO2010143733A1 Novel fused cyclic compound and use thereof
12/16/2010WO2010142934A1 Indole derivatives as ligands of crth2 receptors
12/16/2010WO2010142801A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010WO2010142137A1 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
12/16/2010WO2010129467A8 Compounds and methods for inhibition of renin, and indications therefor
12/16/2010WO2010116088A3 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
12/16/2010WO2010052569A3 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
12/16/2010US20100317872 Therapeutic compounds
12/16/2010US20100317848 Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
12/16/2010US20100317709 Sphingosine-1-phosphate (s1p) receptor compounds
12/16/2010US20100317693 3,8-diaminotetrahydroquinoline derivative
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317648 Therapeutic compounds
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317630 Novel heterocyclic compounds as mglu5 antagonists
12/16/2010US20100314615 Aromatic amine derivative and organic electroluminescent device using the same
12/16/2010CA2802334A1 Compositions and methods for imaging tissues, organs and tumors
12/16/2010CA2765181A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010CA2765030A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2762916A1 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
12/15/2010EP2261224A2 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors
12/15/2010EP2261218A2 Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
12/15/2010EP2261213A1 Heterocyclic compound
12/15/2010EP2048145B1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
12/15/2010EP2000465B1 Triazolone derivative
12/15/2010EP1740578B1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
12/15/2010CN1984660B 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
12/15/2010CN1887033B Charge-transporting organic material containing compound having 1,4-dithiin ring
12/15/2010CN101918386A 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides
12/15/2010CN101918369A N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (HCV) inhibitors
12/15/2010CN101918365A Inhibitors of human immunodeficiency virus replication
12/15/2010CN101918362A Pyridine derivatives
12/15/2010CN101918360A Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
12/15/2010CN101914093A Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates
12/15/2010CN101913555A Method for preparing tetrathiafulvalene molecule-based micrometer and/or nanometer functional materials
12/15/2010CN101171238B (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-HT receptor
12/14/2010US7851634 enzyme inhibitors such as N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2-isopropyl-7-[3-(3-methoxypropyl)-1H-indol-5-ylmethyl]-8-methylnonanamide, used as hypotensive agents
12/14/2010US7851632 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation
12/14/2010US7851471 Compounds I
12/14/2010CA2535199C Amide derivative
12/14/2010CA2430909C Inhibitors of papilloma virus
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/09/2010WO2010141805A1 Heterocyclic amides as modulators of trpa1
12/09/2010WO2010140802A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/09/2010WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier
12/09/2010US20100311795 1,3-dioxane carboxylic acids
12/09/2010US20100311789 3-Substituted Propanamine Compounds
12/09/2010US20100311582 Chemical compounds
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010DE102010006488A1 Thiophenderivate und diese enthaltende FK-Medien Thiophene derivatives and to LC media
12/09/2010CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells
12/08/2010EP2258703A1 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258690A1 Tricyclic amines as intermediates in the synthesis of fungicidal carboxamide derivatives
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258366A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
12/08/2010EP2257548A1 Therapeutic compounds
12/08/2010EP2257545A1 Pyrrolidinyl derivatives and uses thereof
12/08/2010EP2257541A1 Modulators for amyloid beta
12/08/2010EP2257534A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257528A2 1 ibeta-hydroxysteroid dehydrogenase inhibitors
12/08/2010EP2257297A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
12/08/2010EP2257167A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
12/08/2010EP2257160A1 Diamide inhibitors of cytochrome p450
12/08/2010EP1891011B1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
12/08/2010EP1628685B1 Antiviral phosphonate analogs
12/08/2010CN101910157A Indole compounds and methods for treating visceral pain
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910131A Carboxamide, sulfonamide and amine compounds for metabolic disorders
12/08/2010CN101910129A Synthesis of quaternary salt compounds
12/08/2010CN101910126A Proline analogs as ligands for cannabinoid receptors for the treatment of pain
12/08/2010CN101910121A Bis-(sulfonylamino) derivatives in therapy 066
12/08/2010CN101906095A Thioxathone-4-carboxylic ester and preparation method as well as photoinitiator composition and application
12/08/2010CN101906029A Flavonoid derivative , preparation method thereof and use thereof
12/08/2010CN101497426B Method for preparing tetrathiafulvalene molecule-based micrometre and/or nano functional material
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 523